Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### Centers for Disease Control and Prevention

# AGENCY:

Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS).

# ACTION:

Notice of meeting.

# SUMMARY:

In accordance with the Federal Advisory Committee Act, the Centers for Disease Control and Prevention (CDC) announces the following meeting for the Subcommittee on Procedures Reviews (SPR) of the Advisory Board on Radiation and Worker Health (ABRWH or the Advisory Board). This meeting is open to the public, but without a public comment period. The public is welcome to submit written comments in advance of the meeting, to the contact person below. Written comments received in advance of the meeting will be included in the official record of the meeting. The public is also welcomed to listen to the meeting by joining the audio conference (information below). The audio conference line has 150 ports for callers.

# DATES:

The meeting will be held on November 8, 2024, from 11 a.m. to 4:30 p.m., EST. Written comments must be received on or before November 1, 2024.

# ADDRESSES:

You may submit comments by mail to: Rashaun Roberts, Ph.D., National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, 1090 Tusculum Avenue, MS C-24, Cincinnati, Ohio 45226.

*Meeting Information:*                         Audio Conference Call via FTS Conferencing. The USA toll-free dial-in number is 1-866-659-0537; the pass code is 9933701.                    

# FOR FURTHER INFORMATION CONTACT:

                        Rashaun Roberts, Ph.D., Designated Federal Officer, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, 1090 Tusculum Avenue, Mailstop C-24, Cincinnati, Ohio 45226, Telephone: (513) 533-6800, Toll Free 1(800) CDC-INFO, Email:                         *ocas@cdc.gov.*

# SUPPLEMENTARY INFORMATION:

*Background:*                     The Advisory Board was established under the Energy Employees Occupational Illness Compensation Program Act of 2000 to advise the President on a variety of policy and technical functions required to implement and effectively manage the new compensation program. Key functions of the Advisory Board include providing advice on the development of probability of causation guidelines that have been promulgated by the Department of Health and Human Services (HHS) as a final rule; advice on methods of dose reconstruction, which have also been promulgated by HHS as a final rule; advice on the scientific validity and quality of dose estimation and reconstruction efforts being performed for purposes of the compensation program; and advice on petitions to add classes of workers to the Special Exposure Cohort (SEC). In December 2000, the President delegated responsibility for funding, staffing, and operating the Advisory Board to HHS, which subsequently delegated this authority to CDC. NIOSH implements this responsibility for CDC.                

                    The charter was issued on August 3, 2001, renewed at appropriate intervals, and rechartered under Executive Order 14109 (September 29, 2023) on March 22, 2024. Unless continued by the President the Board will terminate on                           ( print page 77156)                        September 30, 2025, consistent with E.O. 14109 (September 29, 2023).                

*Purpose:*                     The Advisory Board is charged with (a) providing advice to the Secretary, HHS, on the development of guidelines under Executive Order 13179; (b) providing advice to the Secretary, HHS, on the scientific validity and quality of dose reconstruction efforts performed for this program; and (c) upon request by the Secretary, HHS, advise the Secretary on whether there is a class of employees at any Department of Energy facility who were exposed to radiation but for whom it is not feasible to estimate their radiation dose, and on whether there is reasonable likelihood that such radiation doses may have endangered the health of members of this class. The ABRWH Subcommittee on Procedure Reviews (SPR) is responsible for overseeing, tracking, and participating in the reviews of all procedures used in the dose reconstruction process by the NIOSH Division of Compensation Analysis and Support (DCAS) and its dose reconstruction contractor (Oak Ridge Associated Universities—ORAU).                

*Matters to be Considered:*                     The meeting agenda will include discussions on the following: (1) Carry-over items from March 14, 2024 SPR meeting, including a. DCAS-PER-040 “Mallinckrodt TBD Revisions,” b. DCAS-PER-068 “Electro Metallurgical Co”, c. DCAS-PER-070 “Nuclear Metals Inc.”, d. DCAS-PER-072 “Seymour Specialty Wiring Co”, e. ORAUT-RPRT-0060 “Neutron Dose from Highly Enriched Uranium”, and f. DR template reviews—findings versus observations; (2) Newly issued SC&A reviews, including a. ORAUT-OTIB-0036 “Internal Dosimetry Coworker Data for Portsmouth Gaseous Diffusion Plant” b. ORAUT-OTIB-0040 “External Coworker Dosimetry Data for the Portsmouth Gaseous Diffusion Plant” c. ORAUT-OTIB-0093 “Conversion of Committed Effective Dose to Annual Organ Dose” and d. ORAUT-RPRT-0087 “Applications of Regression in External Dose Reconstruction”; (3) Preparation for August 2024 Full ABRWH Meeting: Review of technical guidance documents ready for full Board approval; (4) Newly Issued Guidance and Supplemental Topics. Agenda items are subject to change as priorities dictate. For additional information, please contact Toll Free 1(800) 232-4636.                

                    The Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign                     **Federal Register**                     notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.                

Kalwant Smagh,

Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention.

[FR Doc. 2024-21497 Filed 9-19-24; 8:45 am]

BILLING CODE 4163-18-P